**Abstract**

Psychotherapy and pharmacotherapy have been the mainstays for the treatment of depression and anxiety disorders during the last century. However, treatment response has not improved in the last few decades. For instance, only half of all patients respond to mainstay antidepressants. To fulfill the needs of the remaining patients, there is a need to find treatments with better efficacy. The addition of psychotherapy to antidepressant treatment has been proven to be superior to either treatment alone. However, the time costs of psychotherapy limit its use for clinicians and patients. Advancements in neuroscience have contributed to an improved understanding of the pathogenesis of depressive and anxiety disorders. In particular, recent advances in the field of fear conditioning provide valuable insight into the treatment of refractory depressive and anxiety disorders. In this review, we studied the reconsolidation-updating paradigm and the concept of epigenetic modification, which has been shown to permanently attenuate remote fear memory. This has implications for drug-augmented psychotherapy. Future research on more sophisticated psychotherapy techniques will make this treatment modality more favorable to both clinicians and patients.
